Idera Pharmaceuticals reported $0 in Sales Revenues for its fourth fiscal quarter of 2020.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Abbott ABT:US $ 10928M 705M
Aceto ACET:US 3.43M 1.38M
Agenus AGEN:US $ 252.95M 242.22M
Alnylam Pharmaceuticals ALNY:US $ 187.63M 32.92M
Amgen AMGN:US $ 6706M 180M
Biogen BIIB:US $ 2778.9M 3.9M
Biomarin Pharmaceutical BMRN:US $ 408.74M 92.95M
Cytrx CYTR:US 0 0
Dynavax Technologies DVAX:US $ 108.27M 55.5M
Eli Lilly And LLY:US $ 6772.8M 32.7M
Gilead Sciences GILD:US $ 7421M 1204M
GlaxoSmithKline GSK:LN 9077M 985M
Merk MRK:US $ 13154M 1752M
Mirati Therapeutics MRTX:US $ 71.79M 71.79M
Nektar Therapeutics NKTR:US $ 24.92M 3.41M
Pfizer PFE:US $ 24094M 5117M
Sarepta Therapeutics SRPT:US $ 189.41M 25.32M
Seattle Genetics SGEN:US $ 424.06M 35.58M
Ultragenyx Pharmaceutical RARE:US $ 81.65M 5.33M